液体负荷或血管加压药试验对毛细血管再充盈时间的反应:一项观察性、概念验证研究
该观察性、概念验证研究纳入34例初始复苏后毛细血管再充盈时间(CRT)异常的脓毒性休克患者。9例液体反应性患者接受液体负荷(500 ml/30 min),25例患者通过增加去甲肾上腺素剂量使平均动脉压达到80-85 mmHg并维持30 min(血管加压药试验)。液体负荷后CRT从5 [3.5-7.6]秒降至4 [2.4-5.1]秒(p=0.008),7/9例出现CRT反应;血管加压药试验后CRT从4.0 [3.3-5.6]秒降至3 [2.6-5]秒(p=0.03),14/25例出现CRT反应,但该组4例CRT恶化,均同时使用低剂量血管加压素。作者认为液体负荷可能改善或对CRT无影响,而提高去甲肾上腺素剂量目标的反应更异质。
要点
- 液体负荷(500 ml/30 min)后CRT从5 [3.5-7.6]秒降至4 [2.4-5.1]秒(p=0.008),9例液体反应性患者中7例出现CRT反应。
- 血管加压药试验(去甲肾上腺素剂量增至MAP 80-85 mmHg维持30 min)后CRT从4.0 [3.3-5.6]秒降至3 [2.6-5]秒(p=0.03),25例中14例出现CRT反应。
- 血管加压药试验组4例CRT恶化,均同时接受低剂量血管加压素。
- 初始复苏后CRT异常的脓毒性休克患者,液体负荷可能改善CRT或产生中性效应(作者结论)。
- 对既往高血压的液体无反应患者提高去甲肾上腺素剂量目标使MAP达80-85 mmHg,CRT反应更异质,部分患者皮肤灌注恶化,作者认为值得进一步研究。
适用人群与场景
- 脓毒性休克患者,初始复苏后CRT异常;共纳入34例。
- 液体负荷用于9例液体反应性患者;血管加压药试验用于25例患者(原文提及其中为慢性高血压的液体无反应患者)。
诊断标准与关键阈值
- 以CRT作为组织低灌注标志物,入组时CRT异常。
- 液体反应性在基线评估,液体负荷方案为500 ml/30 min。
- 血管加压药试验目标为平均动脉压80-85 mmHg,持续30 min。
处置流程与药物剂量
- 对液体反应性患者给予液体负荷500 ml/30 min。
- 对慢性高血压的液体无反应患者,增加去甲肾上腺素剂量使平均动脉压达到80-85 mmHg并维持30 min。
- 采用多模式灌注和血流动力学监测方案,至少在基线及干预结束时两个时间点评估。
研究设计与关键结果
- 观察性、概念验证研究,纳入34例脓毒性休克患者。
- 液体负荷后CRT从5 [3.5-7.6]秒降至4 [2.4-5.1]秒(p=0.008),9例中7例出现CRT反应。
- 血管加压药试验后CRT从4.0 [3.3-5.6]秒降至3 [2.6-5]秒(p=0.03),25例中14例出现CRT反应。
- 血管加压药试验组4例CRT恶化,均同时接受低剂量血管加压素。
证据类型、等级与局限
- 证据类型:观察性、概念验证研究。
- 局限:作者指出血管加压药试验后CRT反应异质、部分患者皮肤灌注恶化这一事实值得进一步研究。
对床旁实践的改变
- 作者认为,对液体反应性、持续低灌注的脓毒性休克患者,快速补液可能改善CRT或产生中性效应。
- 作者指出,对既往高血压患者提高去甲肾上腺素剂量以追求更高MAP目标时,CRT反应更异质,多数改善但部分患者皮肤灌注恶化。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Several studies have validated capillary refill time (CRT) as a marker of tissue hypoperfusion, and recent guidelines recommend CRT monitoring during septic shock resuscitation. Therefore, it is relevant to further explore its kinetics of response to short-term hemodynamic interventions with fluids or vasopressors. A couple of previous studies explored the impact of a fluid bolus on CRT, but little is known about the impact of norepinephrine on CRT when aiming at a higher mean arterial pressure (MAP) target in septic shock. We designed this observational study to further evaluate the effect of a fluid challenge (FC) and a vasopressor test (VPT) on CRT in septic shock patients with abnormal CRT after initial resuscitation. Our purpose was to determine the effects of a FC in fluid-responsive patients, and of a VPT aimed at a higher MAP target in chronically hypertensive fluid-unresponsive patients on the direction and magnitude of CRT response.
METHODS: Thirty-four septic shock patients were included. Fluid responsiveness was assessed at baseline, and a FC (500 ml/30 mins) was administered in 9 fluid-responsive patients. A VPT was performed in 25 patients by increasing norepinephrine dose to reach a MAP to 80-85 mmHg for 30 min. Patients shared a multimodal perfusion and hemodynamic monitoring protocol with assessments at at least two time-points (baseline, and at the end of interventions).
RESULTS: CRT decreased significantly with both tests (from 5 [3.5-7.6] to 4 [2.4-5.1] sec, p = 0.008 after the FC; and from 4.0 [3.3-5.6] to 3 [2.6 -5] sec, p = 0.03 after the VPT. A CRT-response was observed in 7/9 patients after the FC, and in 14/25 pts after the VPT, but CRT deteriorated in 4 patients on this latter group, all of them receiving a concomitant low-dose vasopressin.
CONCLUSIONS: Our findings support that fluid boluses may improve CRT or produce neutral effects in fluid-responsive septic shock patients with persistent hypoperfusion. Conversely, raising NE doses to target a higher MAP in previously hypertensive patients elicits a more heterogeneous response, improving CRT in the majority, but deteriorating skin perfusion in some patients, a fact that deserves further research.
参考来源
- Hernández G, Valenzuela ED, Kattan E, et al. Capillary refill time response to a fluid challenge or a vasopressor test: an observational, proof-of-concept study. Ann Intensive Care. 2024. PMID: 38558268. doi:10.1186/s13613-024-01275-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。